Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
389
datasets available to search
ShareScore release 0.9.0
Dataset results
389 results for “Acute myeloid leukemia (AML)”
Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01397799. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents
ClinicalTrials.gov study NCT00111345. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) Mutation
ClinicalTrials.gov study NCT02984995. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02641002. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del
ClinicalTrials.gov study NCT00885508. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML）
ClinicalTrials.gov study NCT01690507. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT01211457. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
ClinicalTrials.gov study NCT05907057. IPD Sharing: YES. Countries: 4. Publications: 1.
A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old
ClinicalTrials.gov study NCT00927498. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)
ClinicalTrials.gov study NCT00266136. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01488344. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02834390. IPD Sharing: YES. Countries: 1. Publications: 0.
Pharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML): a Covariate Analysis With
ClinicalTrials.gov study NCT03796533. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Muta
ClinicalTrials.gov study NCT00893399. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
ClinicalTrials.gov study NCT04093505. IPD Sharing: NO. Countries: 1. Publications: 1.
Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00188136. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03671564. IPD Sharing: YES. Countries: 1. Publications: 0.
Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT02575963. IPD Sharing: NO. Countries: 2. Publications: 4.
Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04657081. IPD Sharing: NO. Countries: 3. Publications: 0.
Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01295307. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.